glp-1 dementia study NEW STUDY: meds slash risk by 33%. This common diabetes medication might be your best weapon yet against dementia. Dementia is affecting millions worldwide, stealing memories and independence. But groundbreaking GLP-1 and Alzheimer's Disease: Research

A 20-week bi-weekly dose escalation phase preceded maintenance dosing

Jensterle M, Herman R, Jane A

If you use this site, you will likely need assistance or a very flexible approach to reaching behind your arm with the syringe

Our LC/MS, GC/MS, and ICP-MS platforms provide trusted answers across the product lifecycle, enabling safe and compliant scale-up. Beyond compliance, sustainability is emerging as a major differentiator

Temperature fluctuations from placement occur when peptides are stored near frequently accessed areas

Angiopoietin-like 3-derivative LNA043 for cartilage regeneration in osteoarthritis: a randomized phase 1 trial